Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits

Journal of Psychiatric Research

Volumn 41, Issue 1-2, 2007, Pages 49-56

  Shimizu, Eiji ^a   Hashimoto, Kenji ^a   Ochi, Shigehiro ^b   Fukami, Goro ^a   Fujisaki, Mihisa ^a   Koike, Kaori ^a   Okamura, Naoe ^a   Ohgake, Shintaro ^a   Koizumi, Hiroki ^a   Matsuzawa, Daisuke ^a   Zhang, Lin ^a   Watanabe, Hiroyuki ^a   Nakazato, Michiko ^a   Shinoda, Naoyuki ^a   Komatsu, Naoya ^a   Morita, Fuminori ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cingulate gyrus; N Acetylaspartate (NAA); Proton magnetic resonance spectroscopy (1H MRS); Retrosplenial cortex; Schizophrenia; Wechsler Memory Scale Revised (WMS R)

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SEX RATIO; TEMPORAL LOBE;

ADULT; ASPARTIC ACID; BRIEF PSYCHIATRIC RATING SCALE; CHRONIC DISEASE; COGNITION DISORDERS; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHOCREATINE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE; WECHSLER SCALES;

EID: 33750733877     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2005.04.015     Document Type: Article

References (63)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington (DC): American Psychiatric Press; 1994.
2. Andreasen N.C., O'Leary D.S., Cizadlo T., Arndt S., Rezai K., Watkins G.L., et al. Remembering the past: two facets of episodic memory explored with positron emission tomography. Am J Psychiatry 152 (1995) 1576-1585
3. Baslow M.H. N-Acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28 (2003) 941-953
4. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 153 (1996) 1554-1563
5. Bertolino A., Kumra S., Callicott J.H., Mattay V.S., Lestz R.M., Jacobsen L., et al. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 155 (1998) 1376-1383
6. Bertolino A., Esposito G., Callicott J.H., Mattay V.S., Van Horn J.D., Frank J.A., et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 157 (2000) 26-33
7. Bertolino A., Callicott J.H., Mattay V.S., Weidenhammer K.M., Rakow R., Egan M.F., et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 49 (2001) 39-46
8. Bilder R.M., Lipschutz-Broch L., Reiter G., Geisler S.H., Mayerhoff D.I., and Lieberman J.A. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 18 (1992) 437-448
9. Bland J.M., and Altman D.G. Multiple significance tests: the Bonferroni method. BMJ 310 (1995) 170
10. Braff D.L., Heaton R., Kuck J., Cullum M., Moranville J., Grant I., et al. The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch Gen Psychiatry 48 (1991) 891-898
11. Bruder G.E., Wexler B.E., Sage M.M., Gil R.B., and Gorman J.M. Verbal memory in schizophrenia: additional evidence of subtypes having different cognitive deficits. Schizophr Res 68 (2004) 137-147
12. Buckley P.F., Moore C., Long H., Larkin C., Thompson P., Mulvany F., et al. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 36 (1994) 792-800
13. Camicioli R.M., Korzan J.R., Foster S.L., Fisher N.J., Emery D.J., Bastos A.C., et al. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett 354 (2004) 177-180
14. Desgranges B., Baron J.C., and Eustache F. The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areas. Neuroimage 8 (1998) 198-213
15. Deicken R.F., Zhou L., Schuff N., Fein G., and Weiner M.W. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry 43 (1998) 483-488
16. Delamillieure P., Constans J.M., Fernandez J., Brazo P., Benali K., Courtheoux P., et al. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr Bull 28 (2002) 329-339
17. Delamillieure P., Fernandez J., Constans J.M., Brazo P., Benali K., Abadie P., et al. Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report. Am J Psychiatry 157 (2000) 641-643
18. Dickinson D., Iannone V.N., Wilk C.M., and Gold J.M. General and specific cognitive deficits in schizophrenia. Biol Psychiatry 55 (2004) 826-833
19. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Rawlings R., Hyde T.M., et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry 50 (2001) 98-107
20. Elvevag B., and Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14 (2000) 1-21
21. Fannon D., Simmons A., Tennakoon L., O'Ceallaigh S., Sumich A., Doku V., et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol Psychiatry 54 (2003) 587-598
22. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.G., Storts R.W., et al. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123 (1993) 204-215
23. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., and Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 11 (1989) 47-63
24. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., et al. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Res 61 (1995) 193-200
25. Gold J.M., and Weinberger D.R. Cognitive deficits and the neurobiology of schizophrenia. Curr Opin Neurobiol 5 (1995) 225-230
26. Hashimoto K., and Iyo M. Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs. Nihon Shinkei Seishin Yakurigaku Zasshi 22 (2002) 3-13 Japanese
27. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., et al. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60 (2003) 572-576
28. Heimberg C., Komoroski R.A., Lawson W.B., Cardwell D., and Karson C.N. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res 83 (1998) 105-115
29. Heydebrand G., Weiser M., Rabinowitz J., Hoff A.L., DeLisi L.E., and Csernansky J.G. Correlates of cognitive deficits in first episode schizophrenia. Schizophr Res 68 (2004) 1-9
30. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
31. Jenkins B.G., Klivenyi P., Kustermann E., Andreassen O.A., Ferrante R.J., Rosen B.R., et al. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem 74 (2000) 2108-2119
32. 1H MRS study. Neurology 55 (2000) 210-217
33. Kolakowska T. Brief psychiatric rating scale (1976), Oxford University Press, Oxford
34. Maier M., Ron M.A., Barker G.J., and Tofts P.S. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol Med 25 (1995) 1201-1209
35. Miller B.L. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 4 (1991) 47-52
36. Minoshima S., Foster N.L., and Kuhl D.E. Posterior cingulate cortex in Alzheimer's disease. Lancet 344 (1994) 895
37. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., and Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42 (1997) 85-94
38. Mohamed S., Paulsen J.S., O'Leary D., Arndt S., and Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 56 (1999) 749-754
39. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 258 (1992) 597-603
40. Nasrallah H.A., Skinner T.E., Schmalbrock P., and Robitaille P.M. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br J Psychiatry 165 (1994) 481-485
41. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., et al. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20 (1999) 106-118
42. Nyberg L., McIntosh A.R., Cabeza R., Nilsson L.G., Houle S., Habib R., et al. Network analysis of positron emission tomography regional cerebral blood flow data: ensemble inhibition during episodic memory retrieval. J Neurosci 16 (1996) 3753-3759
43. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 (1971) 97-113
44. Olney J.W., Labruyere J., and Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 (1989) 1360-1362
45. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52 (1995) 998-1007
46. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychol Rep 10 (1962) 799-812
47. Pantelis C., Barnes T.R., Nelson H.E., Tanner S., Weatherley L., Owen A.M., et al. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120 (1997) 1823-1843
48. Shallice T., Fletcher P., Frith C.D., Grasby P., Frackowiak R.S., and Dolan R.J. Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 368 (1994) 633-635
49. Sharma T., and Antonova L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am 26 (2003) 25-40
50. Shimizu E., Tang Y.P., Rampon C., and Tsien J.Z. NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation. Science 290 (2000) 1170-1174
51. Spreen O., and Strauss E. A compendium of neuropsychological tests. Administration, norms, and commentary (1991), Oxford University Press, New York
52. Sugishita M., and Omura K. Learning Chinese characters may improve visual recall. Percept Mot Skills 93 (2001) 579-594
53. Reitan R.M., and Wolfson D. The Halstead-Reitan Neuropsychological Test Battery (1985), Neuropsychology Press, Tucson
54. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., et al. Genetic enhancement of learning and memory in mice. Nature 401 (1999) 63-69
55. Tsai G., and Coyle J.T. N-Acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 46 (1995) 531-540
56. Tsai G., and Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42 (2002) 165-179
57. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., and Javitt D.C. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57 (2000) 1139-1147
58. Valenstein E., Bowers D., Verfaellie M., Heilman K.M., Day A., and Watson R.T. Retrosplenial amnesia. Brain 110 (1987) 1631-1646
59. Webb P.G., Sailasuta N., Kohler S.J., Raidy T., Moats R.A., and Hurd R.E. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 31 (1994) 365-373
60. Wechsler D.A. Wechsler memory scale-revised, manual (1987), Psychological Corp., New York
61. Weickert T.W., Goldberg T.E., Gold J.M., Bigelow L.B., Egan M.F., and Weinberger D.R. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 57 (2000) 907-913
62. Wexler B.E., Stevens A.A., Bowers A.A., Sernyak M.J., and Goldman-Rakic P.S. Word and tone working memory deficits in schizophrenia. Arch Gen Psychiatry 55 (1998) 1093-1096
63. Yurgelun-Todd D.A., Renshaw P.F., Gruber S.A., Ed M., Waternaux C., and Cohen B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and healthy controls. Schizophr Res 19 (1996) 55-59